These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7986498)

  • 21. Treatment of blepharospasm with botulinum toxin. A preliminary report.
    Frueh BR; Felt DP; Wojno TH; Musch DC
    Arch Ophthalmol; 1984 Oct; 102(10):1464-8. PubMed ID: 6385932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Singer M
    Ophthalmology; 1996 Mar; 103(3):348. PubMed ID: 8600402
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study.
    Taylor JD; Kraft SP; Kazdan MS; Flanders M; Cadera W; Orton RB
    Can J Ophthalmol; 1991 Apr; 26(3):133-8. PubMed ID: 2054723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemifacial spasm treated with botulinum A toxin injection.
    Savino PJ; Sergott RC; Bosley TM; Schatz NJ
    Arch Ophthalmol; 1985 Sep; 103(9):1305-6. PubMed ID: 4038122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of blepharospasm, hemifacial spasm and strabismus with botulinum a toxin.
    Dai Z; Wang YC
    Chin Med J (Engl); 1992 Jun; 105(6):476-80. PubMed ID: 1451548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injection therapy for hemifacial spasm.
    Tolosa E; Martí MJ; Kulisevsky J
    Adv Neurol; 1988; 49():479-91. PubMed ID: 3344638
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemifacial spasm treated with botulinum toxin].
    Jedynak CP; Palfi S; Vidailhet M; Kullmann B
    Rev Neurol (Paris); 1993; 149(3):202-6. PubMed ID: 8235213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin.
    Clark GT
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):727-48. PubMed ID: 14580034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin treatment of hemifacial spasm.
    Elston JS
    J Neurol Neurosurg Psychiatry; 1986 Jul; 49(7):827-9. PubMed ID: 3746313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
    Carruthers J; Stubbs HA
    Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of facial spasm with oculinum (Clostridium botulinum toxin): a preliminary report.
    Biglan AW; May M; Walden PG
    Am J Otol; 1986 Jan; 7(1):65-70. PubMed ID: 3946586
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin in the treatment of facial dyskinesias.
    Chong PN; Ong B; Chan R
    Ann Acad Med Singap; 1991 Mar; 20(2):223-7. PubMed ID: 1883180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum).
    Biglan AW; May M; Bowers RA
    Arch Otolaryngol Head Neck Surg; 1988 Dec; 114(12):1407-12. PubMed ID: 3056454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Ainsworth JR; Kraft SP
    Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.